cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rigel Pharmaceuticals Inc
23 own
25 watching
Current Price
$0
$-0.03
(-1.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
290.37M
52-Week High
52-Week High
3.515
52-Week Low
52-Week Low
0.64
Average Volume
Average Volume
0.58M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization290.37M
icon52-Week High3.515
icon52-Week Low0.64
iconAverage Volume0.58M
iconDividend Yield--
iconP/E Ratio--
What does the Rigel Pharmaceuticals Inc do?
Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of drugs in the therapeutic areas of immunology, oncology, and immuno-oncology. The company's clinical programs include fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, which has completed Phase III clinical program for immune thrombocytopenia purpura; and Phase II clinical study for autoimmune hemolytic anemia and IgA nephropathy. It is also developing two oncology product candidates, which are in Phase I and Phase II. Rigel Pharmaceuticals, Inc. has license agreements with Aclaris Therapeutics International Limited for the development and commercialization of janus kinase (JAK) inhibitors for the treatment of alopecia areata and other dermatological conditions; Bristol-Myers Squibb Company for the discovery, development, and commercialization of cancer immunotherapies; AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of an oncology program; and Daiichi Sankyo to pursue research related to ligases. The company was founded in 1996 and is based in South San Francisco, California.
Read More
How much money does Rigel Pharmaceuticals Inc make?
News & Events about Rigel Pharmaceuticals Inc.
PR Newswire
1month ago
Thinking about buying stock in 180 Life Sciences, HTG Molecular, Markforged, Icecure Medical, or Rigel Pharmaceuticals? Thinking about buying stock in 180 Life Sciences, HTG Molecular, Markforged, Icecure Medical, or Rigel Pharmaceuticals? PR Newswire NEW YORK, Dec. 27, 2022 NEW YORK, Dec. 27, 2022...
PR Newswire
1month ago
Rigel Announces Availability of REZLIDHIA (olutasidenib) in the U.S. for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation Rigel Announces Availability of REZLIDHIA (olutasidenib) in the U.S. for the Treatment of Adult Patients with...
PR Newswire
1month ago
Thinking about buying stock in 180 Life Sciences, Viking Therapeutics, Camber Energy, New Oriental Education & Tech, or Rigel Pharmaceuticals? Thinking about buying stock in 180 Life Sciences, Viking Therapeutics, Camber Energy, New Oriental Education & Tech, or Rigel...
PR Newswire
2 months ago
Thinking about buying stock in Rigel Pharmaceuticals, Mullen Automotive, COMSovereign, Credit Suisse, or Tilray? Thinking about buying stock in Rigel Pharmaceuticals, Mullen Automotive, COMSovereign, Credit Suisse, or Tilray? PR Newswire NEW YORK, Dec. 2, 2022 NEW YORK, Dec. 2, 2022 /PRNewswire...
PR Newswire
3 months ago
Rigel Announces Five Poster Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition Rigel Announces Five Poster Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 3...
Frequently Asked Questions
Frequently Asked Questions
What is Rigel Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Rigel Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Rigel Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Rigel Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rigel Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Rigel Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Rigel Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rigel Pharmaceuticals Inc?
plus_minus_icon
What percentage is Rigel Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rigel Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.03
(-1.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00